F. Hoffmann-La Roche Ltd - Company Profile
Powered by 
All the data and insights you need on F. Hoffmann-La Roche Ltd in one report.
$295
- Save hours of research time and resources with
our up-to-date F. Hoffmann-La Roche Ltd Strategy Report
- Understand F. Hoffmann-La Roche Ltd position in the market,
performance and strategic initiatives.
- Gain competitive edge and increase your
chances of success
Related keylists
View moreF. Hoffmann-La Roche Ltd (Roche) is a biotechnology company that develops drugs and diagnostics to treat major diseases. It provides medicines for the treatment of cancer, other auto-immune diseases, central nervous system disorders, ophthalmological disorders, infectious diseases, and respiratory diseases. The company also offers in vitro diagnostics, tissue-based cancer diagnostics, and diabetes management solutions. Roche conducts research to identify novel methods to prevent, diagnose, and treat diseases. The company offers its products and services to hospitals, healthcare professionals, commercial laboratories, researchers, and pharmacists. Together with its subsidiaries and partners, the company has operations in various countries. Roche is headquartered in Basel, Switzerland.
Headquarters
Switzerland
Address
Grenzacherstrasse 124, Basel, 4070
Website
www.roche.com
Telephone
41 61 6919391
No of Employees
103,613
Industry
Pharmaceuticals and Healthcare
Ticker Symbol & Exchange
ROG (SWF)
Revenue (2022)
$66.3B
0.8%
(2022 vs 2021)
EPS
XYZ
Net Income (2022)
XYZ
-10.8%
(2022 vs 2021)
Market Cap*
$238.1B
Net Profit Margin (2022)
XYZ
-11.5%
(2022 vs 2021)
* As of and is in US$
F. Hoffmann-La Roche Ltd premium industry data and analytics
Products and Services
| Products | Brands |
|---|---|
| Product Categories: | Accu-Chek |
| Pharmaceuticals for: | Accutrend |
| Anemia | AmpliChip |
| XYZ | XYZ |
| XYZ | XYZ |
| XYZ | XYZ |
History
History section provides information on new products, mergers, acquisitions, expansions, approvals, and many more key events.
| Year | Event | Description |
|---|---|---|
| 2023 | Contracts/Agreements | In December, the company entered into an agreement to acquire Carmot Therapeutics, Inc. |
| 2023 | Contracts/Agreements | In November, the company announced the expansion of its partnership with Shape under which Shape will use its proprietary AI-powered RNA editing platform to develop a potential one-time therapy for patients with high unmet needs for an undisclosed disease. |
| 2023 | New Products/Services | In November, the company launched Elecsys HBeAg quant. |
Competitor Comparison
| Key Parameters | F. Hoffmann-La Roche Ltd | Pfizer Inc | Johnson & Johnson | Merck & Co Inc | AbbVie Inc |
|---|---|---|---|---|---|
| Headquarters | Switzerland | United States of America | United States of America | United States of America | United States of America |
| City | Basel | New York | New Brunswick | Kenilworth | North Chicago |
| State/Province | - | New York | New Jersey | New Jersey | Illinois |
| No. of Employees | 103,613 | 83,000 | 152,700 | 69,000 | 50,000 |
| Entity Type | Public | Public | Public | Public | Public |
Key Financial Charts
Sales Growth
Net Income Growth
Executives
| Name | Position | Board | Since | Age |
|---|---|---|---|---|
| Severin Schwan | Chairman | Executive Board | 2023 | 56 |
| Matt Sause | Director; Chief Executive Officer - Roche Diagnostics | Executive Board | 2023 | 46 |
| Thomas Schinecker | Chief Executive Officer | Senior Management | 2023 | 48 |
| Cristina A. Wilbur | Chief People Officer | Senior Management | 2016 | 56 |
| Levi Garraway | Head - Global Product Development; Chief Medical Officer | Senior Management | - | 55 |
| Non Dignissim Eros | Proin vel | Convallis | 2023 | XY |
| Non Dignissim Eros | Proin vel | Convallis | 2023 | XY |
| Non Dignissim Eros | Proin vel | Convallis | 2023 | XY |
Still looking?
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Explorer
Access more premium companies when you subscribe to Explorer
Get in touch about GlobalData Company reports
Contact the team or request a demo to find out how our data can drive your business forward